Success Begins Here

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder Home PageNews PagePear Therapeutics

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder

Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital…

Arboretum_JDDecember 10, 2018

Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder News PagePear Therapeutics

Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder

Sandoz, a Novartis division, and Pear Therapeutics, Inc., recently announced the commercial launch of reSET®…

Arboretum_JDNovember 26, 2018

The top 13 VC investors in femtech startups ArboretumNews Page

The top 13 VC investors in femtech startups

Alongside the #MeToo and Time’s Up movements, which are addressing sexual harassment & violence toward…

Arboretum_JDNovember 5, 2018

Arboretum Ventures Fall 2018 Newsletter News PageNewsletter

Arboretum Ventures Fall 2018 Newsletter

View the latest news and updates from Arboretum Ventures.

Arboretum_JDOctober 22, 2018

SI-BONE Announces Pricing of Initial Public Offering Home PageNews PageSI-Bone

SI-BONE Announces Pricing of Initial Public Offering

SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a medical device company that pioneered the minimally invasive surgical…

Arboretum_JDOctober 18, 2018

Cardiac Dimensions Announces DRG Reimbursement Code for Carillon® Mitral Contour System® in Germany Cardiac DimensionsHome PageNews Page

Cardiac Dimensions Announces DRG Reimbursement Code for Carillon® Mitral Contour System® in Germany

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address…

Arboretum_JDOctober 18, 2018

Former Inogen CEO, Ray Huggenberger, Joins Ebb Therapeutics Board of Directors Ebb TherapeuticsNews Page

Former Inogen CEO, Ray Huggenberger, Joins Ebb Therapeutics Board of Directors

Ebb Therapeutics, a med-tech start-up that develops innovative products designed to help the millions of…

Arboretum_JDSeptember 18, 2018

QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing Home PageNeuMoDxNews Page

QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced a…

Arboretum_JDSeptember 17, 2018

Strata Oncology Announces Participation in the NCI-MATCH Clinical Trial Home PageNews PageStrata Oncology

Strata Oncology Announces Participation in the NCI-MATCH Clinical Trial

Strata Oncology, Inc. today announced it is participating as a CLIA-certified/accredited laboratory for the precision…

Arboretum_JDSeptember 6, 2018

Strata Oncology Receives Nomination for Up-and-Coming Company of the Year by Michigan Venture Capital Association News PageStrata Oncology

Strata Oncology Receives Nomination for Up-and-Coming Company of the Year by Michigan Venture Capital Association

Nominees for Exit of the Year, Community Impact Player, and Up-and-Coming Company of the Year…

Arboretum_JDAugust 28, 2018